Integrated BioPharma, Inc.

INBP

US45811V1052

Pharmaceuticals

Delayed OTC Markets Other stock markets 11:38:43 24/06/2024 pm IST			5-day change	1st Jan Change
0.2 ^USD	-10.38%		-10.39%	-18.43%

10/05	Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
12/02	Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Integrated Biopharma, Inc. Announces the Resignation of Joseph Laplaca as Director

November 23, 2016 at 07:51 pm IST

On October 21, 2016, Joseph LaPlaca notified the Board of Directors of Integrated Biopharma Inc. that he does not wish to stand for re-election as a Director at the company’s shareholders meeting to be held on November 28, 2016. His decision is not the result of any disagreement with the company.

Latest news about Integrated BioPharma, Inc.

Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	11/05	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	13/02	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	10/11	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023	16/23/16	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	16/23/16	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	12/23/12	CI
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President	22/23/22	CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement	17/23/17	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	11/23/11	CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022	11/22/11	CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022	14/22/14	CI
Integrated Biopharma, Inc. Announces Change in Directors	22/22/22	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q1 Revenue $15.6M	13/22/13	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	12/22/12	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M	11/22/11	MT
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	11/22/11	CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $12.8M	11/21/11	MT
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	11/21/11	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	03/21/03	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	13/21/13	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020	13/21/13	CI
Integrated BioPharma : Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $15.2M	13/20/13	MT
Integrated Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	13/20/13	CI
Integrated Biopharma, Inc. Appoints Eric Friedman as Director and to the Audit Committee of the Board of Directors	10/20/10	CI
Integrated Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020	24/20/24	CI

Chart Integrated BioPharma, Inc.

Duration

Period

More charts

Company Profile

Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.

Sector

Pharmaceuticals

Calendar

12/09/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
INTEGRATED BIOPHARMA, INC.	-18.43%	6.02M
ELI LILLY AND COMPANY	+54.61%	811B
NOVO NORDISK A/S	+43.56%	640B
JOHNSON & JOHNSON	-6.33%	353B
MERCK & CO., INC.	+20.62%	333B
ABBVIE INC.	+10.44%	302B
ASTRAZENECA PLC	+17.74%	246B
ROCHE HOLDING AG	+2.37%	225B
NOVARTIS AG	+12.62%	218B
AMGEN INC.	+8.61%	168B